Glaxo Operations UK Ltd (manufacturing, quality control)
UkraineAll drugs from this manufacturer
-
The drug is used for the treatment of patients with chronic immune (idiopathic) thrombocytopenic purpura (aged 1 year and older), thrombocytopenia in adults with chronic hepatitis C, as well as for the treatment of adults with severe aplastic anemia.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag 25 mg ATC: B02BX05
-
The drug is used for the treatment of patients with chronic immune (idiopathic) thrombocytopenic purpura (aged 1 year and older), thrombocytopenia in adults with chronic hepatitis C, as well as for the treatment of adults with severe aplastic anemia.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag 50 mg ATC: B02BX05